Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Multi-tasking Molecule Holds Key to Allergic Reactions

11.08.2008
As the summer approaches most of us rejoice, reach for the sunscreen and head outdoors. But an ever-growing number of people reach for tissue instead as pollen leaves eyes watering, noses running and spirits dwindling.

Hay fever is just one of a host of hypersensitivity allergic diseases that cause suffering worldwide and others, such as severe reactions to bee stings or eating peanuts, can be more serious and even fatal.

Now, scientists at the Salk Institute for Biological Studies have uncovered the molecular mechanisms behind such allergies, insight they hope will lead to new therapies, both to stop the summer sneezing and treat more severe allergic responses.

“These results may allow us to develop acute inhibitors of allergic reactions that do not have the side-effects of current treatments such as drowsiness,” says Inder Verma, Ph.D., a professor in the Laboratory of Genetics and senior author of the study published in the August 8 issue of Cell.

When our bodies encounter an allergen (such as pollen), specialized cells called mast cells undergo “de-granulation”, during which they release the chemical histamine. Histamine in turn causes fluid to build up in the surrounding tissue. When this process is working normally it offers protection against the allergen but in people with allergic diseases, de-granulation can occur throughout the body, leading to severe inflammation and in the worst cases, anaphylactic shock and death.

And allergies are a growing problem the world over. “One out of three Japanese people suffer from allergies,” says postdoctoral researcher Kotaro Suzuki, Ph.D., who led the current study.

During de-granulation, histamine is bundled into membrane bound sacks called vesicles, which then transport it to the cell surface. When the vesicles reach the surface they fuse with the outer membrane of the cell, spilling their contents into the extra-cellular space in a process known as exocytosis. To prevent this process from going overboard the scientists first had to understand how de-granulation is regulated.

Their hunch was that the allergic response would involve NF-êB, a protein found in the nucleus that regulates gene expression and was already known to be involved in other types of immune response. To investigate this hypothesis they focused on the role of IKK2, a protein kinase, which is essential for NF-êB activation.

To generate mast cells that were free of IKK2, the researchers transplanted mice that had no mast cells of their own with either normal mast cells or mast cells that lacked IKK2. Strikingly, mice with mast cells lacking IKK2 had reduced allergic reactions. The researchers assumed that the lowered response was due to reduced NF-êB, but to their surprise, inactivating NF-êB signaling alone did not have the same effect. “That was one of the first clues that IKK2 had other roles to play,” says Verma.

“IKK2 knock out mast cells couldn’t release enough histamine,” added Suzuki ‘but we still didn’t know the molecular mechanisms.” What they did know already was that de-granulation requires a collection of proteins — known as the SNARE complex — to assemble at the cell surface.

Suzuki and Verma used biochemical analysis to show that when an allergen is present, IKK2 binds to and activates one particular SNARE component called SNAP-23. Without IKK2, SNAP-23 is missing from the SNARE complex and conversely, when SNAP-23 is permanently activated, removing IKK2 no longer impairs de-granulation. “This is the first major feather on the cap of IKK2 in addition to NF-êB,” says Verma.

But IKK2’s role in the allergic response does not stop there - it multi-tasks. After the rapid “early phase” de-granulation response, mast cells undergo a “late-phase” reaction during which certain genes are turned on to help fight the allergen. Suzuki and Verma showed that the late-phase response also requires IKK2, but that this time it functions by its more usual route - via NF-êB.

The Salk researchers are now testing inhibitors of IKK2 as acute treatment for allergic reactions. Unlike anti-histamines, which are currently used to combat allergies, IKK2 inhibitors would have the added benefit of reducing both the early and late phase allergic responses.

And the newly discovered role for IKK2’s may not be limited to allergic reactions. Many fundamental processes in our bodies involve exocytosis, ranging from secretion of insulin in the pancreas to synaptic transmission, the process by which signals are passed from one nerve cell to another. If IKK2 is involved in these processes it may have a role in other pathologies such as diabetes and nervous system diseases.

The Salk Institute for Biological Studies in La Jolla, California, is an independent nonprofit organization dedicated to fundamental discoveries in the life sciences, the improvement of human health and the training of future generations of researchers. Jonas Salk, M.D., whose polio vaccine all but eradicated the crippling disease poliomyelitis in 1955, opened the Institute in 1965 with a gift of land from the City of San Diego and the financial support of the March of Dimes.

Gina Kirchweger | Newswise Science News
Further information:
http://www.salk.edu

Further reports about: Allergic IKK2 Molecule Multi-tasking NF-êB Verma allergies de-granulation

More articles from Life Sciences:

nachricht Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland

nachricht Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>